EADO 2022 | Treating metastatic melanoma

Eva Muñoz Couselo, MD, PhD, Vall d’Hebrón Hospital, Barcelona, Spain, talks on clinical factors to take into consideration when treating patients with BRAF-mutant metastatic melanoma, including the stage of the disease, whether the patient has brain metastasis and the patients level of lactate dehydrogenase (LDH). This interview took place at the EADO 2022 congress.